Genscript Biotech Corp
HKEX:1548

Watchlist Manager

Genscript Biotech Corp

HKEX:1548

Watchlist

Dividends

Price: 10.92 HKD -0.73% Market Closed

Market Cap: 23.2B HKD

Have any thoughts about
Genscript Biotech Corp?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Estee Lauder Companies Inc NYSE:EL	Consumer products
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Church & Dwight Co Inc NYSE:CHD	Consumer products
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	American Express Co NYSE:AXP	Financial Services
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Target Corp NYSE:TGT	Retail
US	Walt Disney Co NYSE:DIS	Media
US	Mueller Industries Inc NYSE:MLI	Machinery
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 10.92 HKD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

Alert

Genscript Biotech Corp

10.92

-0.08 (-0.73%)

52 Week Range	8.23 23.85
Price Target

We'll email you a reminder when the closing price reaches HKD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Estee Lauder Companies Inc NYSE:EL	US
	Exxon Mobil Corp NYSE:XOM	US
	Church & Dwight Co Inc NYSE:CHD	US
	Pfizer Inc NYSE:PFE	US
	American Express Co NYSE:AXP	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Target Corp NYSE:TGT	US
	Walt Disney Co NYSE:DIS	US
	Mueller Industries Inc NYSE:MLI	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Genscript Biotech Corp

What unique competitive advantages
does Genscript Biotech Corp hold over its rivals?

What risks and challenges
does Genscript Biotech Corp face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Genscript Biotech Corp.

What unique competitive advantages
does Genscript Biotech Corp hold over its rivals?

What risks and challenges
does Genscript Biotech Corp face in the near future?

Summarize the latest earnings call
of Genscript Biotech Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Genscript Biotech Corp.

Provide P/S
for Genscript Biotech Corp.

Provide P/E
for Genscript Biotech Corp.

Provide P/OCF
for Genscript Biotech Corp.

Provide P/FCFE
for Genscript Biotech Corp.

Provide P/B
for Genscript Biotech Corp.

Provide EV/S
for Genscript Biotech Corp.

Provide EV/GP
for Genscript Biotech Corp.

Provide EV/EBITDA
for Genscript Biotech Corp.

Provide EV/EBIT
for Genscript Biotech Corp.

Provide EV/OCF
for Genscript Biotech Corp.

Provide EV/FCFF
for Genscript Biotech Corp.

Provide EV/IC
for Genscript Biotech Corp.

Show me price targets
for Genscript Biotech Corp made by professional analysts.

What are the Revenue projections
for Genscript Biotech Corp?

How accurate were the past Revenue estimates
for Genscript Biotech Corp?

What are the Net Income projections
for Genscript Biotech Corp?

How accurate were the past Net Income estimates
for Genscript Biotech Corp?

What are the EPS projections
for Genscript Biotech Corp?

How accurate were the past EPS estimates
for Genscript Biotech Corp?

What are the EBIT projections
for Genscript Biotech Corp?

How accurate were the past EBIT estimates
for Genscript Biotech Corp?

Compare the revenue forecasts
for Genscript Biotech Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Genscript Biotech Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Genscript Biotech Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Genscript Biotech Corp compared to its peers.

Compare the P/E ratios
of Genscript Biotech Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Genscript Biotech Corp with its peers.

Analyze the financial leverage
of Genscript Biotech Corp compared to its main competitors.

Show all profitability ratios
for Genscript Biotech Corp.

Provide ROE
for Genscript Biotech Corp.

Provide ROA
for Genscript Biotech Corp.

Provide ROIC
for Genscript Biotech Corp.

Provide ROCE
for Genscript Biotech Corp.

Provide Gross Margin
for Genscript Biotech Corp.

Provide Operating Margin
for Genscript Biotech Corp.

Provide Net Margin
for Genscript Biotech Corp.

Provide FCF Margin
for Genscript Biotech Corp.

Show all solvency ratios
for Genscript Biotech Corp.

Provide D/E Ratio
for Genscript Biotech Corp.

Provide D/A Ratio
for Genscript Biotech Corp.

Provide Interest Coverage Ratio
for Genscript Biotech Corp.

Provide Altman Z-Score Ratio
for Genscript Biotech Corp.

Provide Quick Ratio
for Genscript Biotech Corp.

Provide Current Ratio
for Genscript Biotech Corp.

Provide Cash Ratio
for Genscript Biotech Corp.

What is the historical Revenue growth
over the last 5 years for Genscript Biotech Corp?

What is the historical Net Income growth
over the last 5 years for Genscript Biotech Corp?

What is the current Free Cash Flow
of Genscript Biotech Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Genscript Biotech Corp.

Genscript Biotech Corp

Cash Flow Statement

Cash from Operating Activities

Genscript Biotech Corp
Cash from Operating Activities

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

Adjust for Inflation

Genscript Biotech Corp
Cash from Operating Activities Peer Comparison

Comparables:

603259

300759

2269

300347

2268

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company		Cash from Operating Activities	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Genscript Biotech Corp HKEX:1548	Cash from Operating Activities -$19.9m	CAGR 3-Years 45%	CAGR 5-Years 38%	CAGR 10-Years N/A
	WuXi AppTec Co Ltd SSE:603259	Cash from Operating Activities ¥12.8B	CAGR 3-Years 40%	CAGR 5-Years 43%	CAGR 10-Years N/A
	Pharmaron Beijing Co Ltd SZSE:300759	Cash from Operating Activities ¥2.6B	CAGR 3-Years 11%	CAGR 5-Years 24%	CAGR 10-Years N/A
	WuXi Biologics (Cayman) Inc HKEX:2269	Cash from Operating Activities ¥3.2B	CAGR 3-Years 13%	CAGR 5-Years 30%	CAGR 10-Years N/A
	Hangzhou Tigermed Consulting Co Ltd SZSE:300347	Cash from Operating Activities ¥952.7m	CAGR 3-Years -9%	CAGR 5-Years 16%	CAGR 10-Years 32%
W	WuXi XDC Cayman Inc HKEX:2268	Cash from Operating Activities ¥332.8m	CAGR 3-Years 262%	CAGR 5-Years N/A	CAGR 10-Years N/A

What is Genscript Biotech Corp's Cash from Operating Activities?

Cash from Operating Activities
-19.9m USD

Based on the financial report for Jun 30, 2024, Genscript Biotech Corp's Cash from Operating Activities amounts to -19.9m USD.

What is Genscript Biotech Corp's Cash from Operating Activities growth rate?

Cash from Operating Activities CAGR 5Y
38%

Over the last year, the Cash from Operating Activities growth was 92%. The average annual Cash from Operating Activities growth rates for Genscript Biotech Corp have been 45% over the past three years , 38% over the past five years .

Genscript Biotech Corp
HKEX:1548

Genscript Biotech Corp
Cash from Operating Activities

Genscript Biotech Corp
Cash from Operating Activities Peer Comparison

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

See Also

What is Genscript Biotech Corp's Cash from Operating Activities?

Cash from Operating Activities
-19.9m USD

What is Genscript Biotech Corp's Cash from Operating Activities growth rate?

Cash from Operating Activities CAGR 5Y
38%

Company

Help

Tools

Stocks

Genscript Biotech Corp HKEX:1548

Genscript Biotech Corp Cash from Operating Activities

Genscript Biotech Corp Cash from Operating Activities Peer Comparison

Competitive Cash from Operating Activities Analysis Latest Figures & CAGR of Competitors

See Also

What is Genscript Biotech Corp's Cash from Operating Activities? Cash from Operating Activities -19.9m USD

What is Genscript Biotech Corp's Cash from Operating Activities growth rate? Cash from Operating Activities CAGR 5Y 38%

Company

Help

Tools

Stocks

Genscript Biotech Corp
HKEX:1548

Genscript Biotech Corp
Cash from Operating Activities

Genscript Biotech Corp
Cash from Operating Activities Peer Comparison

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

What is Genscript Biotech Corp's Cash from Operating Activities?

Cash from Operating Activities
-19.9m USD

What is Genscript Biotech Corp's Cash from Operating Activities growth rate?

Cash from Operating Activities CAGR 5Y
38%